Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Cardiovasc Revasc Med. 2012 Nov;13(6):311–315. doi: 10.1016/j.carrev.2012.10.003

Table 3.

Adjusted odds ratio model for target vessel and target lesion revascularization

Target Vessel Revascularization Target Lesion Revascularization
Event OR 95% C.I. P-value OR 95% C.I. P-value
Age 10.97 0.96, 0.98 <.0001 0.97 0.95, 0.99 0.001
Diabetes mellitus 1.72 1.25, 2.35 0.0008 2.03 1.33, 3.10 0.0009
History of ISR 1.61 0.95, 2.73 0.08 1.47 0.74, 2.94 0.27
Indication for PCI
 Unstable angina 1.50 0.92, 2.44 0.11 1.87 0.92, 3.80 0.08
 Stable angina 1.39 0.82, 2.38 0.22 1.72 0.80, 3.70 0.16
 Acute MI 0.87 0.50, 1.50 0.61 1.02 0.46, 2.25 0.96
Attempted graft lesion 2.80 1.75, 4.47 <.0001 3.09 1.72, 5.54 0.0002
Attempted ostial lesion 1.49 0.96, 2.32 10.08 1.29 0.71, 2.34 0.41
Long lesion (>30 mm) 1.54 1.02, 2.34 0.04 1.59 0.93, 2.73 0.09
Previously lesion PCI 1.79 1.12, 2.87 0.02 1.86 1.00, 3.43 0.05
SES (vs. other DES) 1.08 10.43, 2.70 0.87 0.69 0.25, 1.91 0.48
PES (vs. other DES) 0.79 0.30, 2.05 0.62 0.43 0.15, 1.27 0.13

ISR- in-stent restenosis, PCI-percutenous coronary intervention, MI-myocardial infarction, SES- sirolimus eluting stent, PES- paclitaxel eluting stent, DES- drug eluting stent